Hyperkalemia with Mineralocorticoid Receptor Antagonist Use in People with CKD Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- March 2022
has subject area
- 1103 Clinical Sciences (FoR)
- Angiotensin-Converting Enzyme Inhibitors (MeSH)
- Female (MeSH)
- Humans (MeSH)
- Hyperkalemia (MeSH)
- Male (MeSH)
- Mineralocorticoid Receptor Antagonists (MeSH)
- Renal Insufficiency, Chronic (MeSH)
- Spironolactone (MeSH)
- Urology & Nephrology (Science Metrix)